WallStreetZenWallStreetZen

NASDAQ: ATHE
Alterity Therapeutics Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ATHE

Based on 1 analyst offering 12 month price targets for Alterity Therapeutics Ltd

Min Forecast
$12.00+218.3%
Avg Forecast
$12.00+218.3%
Max Forecast
$12.00+218.3%

Should I buy or sell ATHE stock?

Based on 1 analyst offering ratings for Alterity Therapeutics Ltd.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ATHE stock forecasts and price targets.

ATHE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-01-30

1 of 1

Forecast return on equity

Is ATHE forecast to generate an efficient return?

Company
-36,940.3%
Industry
780.31%
Market
58.45%
ATHE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ATHE forecast to generate an efficient return on assets?

Company
-27,270.24%
Industry
320.66%
ATHE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ATHE earnings per share forecast

What is ATHE's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.34

ATHE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ATHE$3.77$12.00+218.30%Strong Buy
BRNS$0.99$3.00+203.03%Buy
IRD$1.26$9.00+614.29%Strong Buy
SRZN$12.45$38.50+209.24%Strong Buy
AGEN$1.61$5.00+210.56%Hold
View Top Biotech Stocks

Alterity Therapeutics Stock Forecast FAQ

Is Alterity Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ATHE) stock is to Strong Buy ATHE stock.

Out of 1 analyst, 1 (100%) are recommending ATHE as a Strong Buy, 0 (0%) are recommending ATHE as a Buy, 0 (0%) are recommending ATHE as a Hold, 0 (0%) are recommending ATHE as a Sell, and 0 (0%) are recommending ATHE as a Strong Sell.

If you're new to stock investing, here's how to buy Alterity Therapeutics stock.

What is ATHE's earnings growth forecast for 2025-2025?

(NASDAQ: ATHE) Alterity Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Alterity Therapeutics's earnings in 2025 is -$12,446,299.

In 2025, ATHE is forecast to generate -$1,808,914,280 in earnings, with the lowest earnings forecast at -$1,808,914,280 and the highest earnings forecast at -$1,808,914,280.

What is ATHE's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: ATHE) forecast ROE is -36,940.3%, which is considered weak.

What is ATHE's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ATHE price target, the average ATHE price target is $12.00, with the highest ATHE stock price forecast at $12.00 and the lowest ATHE stock price forecast at $12.00.

The Wall Street analyst predicted that Alterity Therapeutics's share price could reach $12.00 by Jan 30, 2026. The average Alterity Therapeutics stock price prediction forecasts a potential upside of 218.3% from the current ATHE share price of $3.77.

What is ATHE's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: ATHE) Alterity Therapeutics's current Earnings Per Share (EPS) is -$1.25. In 2025, ATHE's EPS is forecast to hit -$0.34 (min: -$0.34, max: -$0.34).

What is ATHE's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: ATHE) forecast ROA is -27,270.24%, which is lower than the forecast US Biotechnology industry average of 320.66%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.